Patents by Inventor Peter Konradsson

Peter Konradsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200239412
    Abstract: Dehydroabietic acid derivatives according to Formula Ia or Formula Ib and all stereoisomers thereof, having a linker chain A of 1 to 10 atoms selected from carbon, nitrogen and oxygen to a group X capable of being negatively charged at a physiological pH and covalently attached to the linker chain A, selected from carboxyl, sulfate, sulfonate and phosphate groups.
    Type: Application
    Filed: September 27, 2018
    Publication date: July 30, 2020
    Inventors: Fredrik ELINDER, Xiongyu WU, Nina OTTOSSON, Peter KONRADSSON, Malin SILVERÅ EJNEBY
  • Publication number: 20180193294
    Abstract: The present invention relates to derivatives of dehydroabietic acid useful in treatment of cardiac arrhythmia or a hyperexcitablity disease, such as epilepsy or pain, by extracellularly acting on the voltage sensitive domain (VSD) to open at least one member of the family of voltage-gated Kv (potassium) channels.
    Type: Application
    Filed: July 11, 2017
    Publication date: July 12, 2018
    Inventors: Fredrik ELINDER, Peter KONRADSSON, Sara LIIN, Nina OTTOSSON, Wu XIONGYU
  • Patent number: 9012656
    Abstract: The present invention relates to oligothiophene derivatives binding specifically to neural stem cells and neural cancer stem cells. More specifically, the invention relates to methods for detecting neural stem cells or neural cancer stem cells using said oligothiophene derivatives in a biological sample, as well as uses and kits relating thereto.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: April 21, 2015
    Assignee: Celluminova AB
    Inventors: Ola Hermansson, Peter Konradsson, Andreas Aslund, Shirin Ilkhanizadeh, Rozalyn Simon, Peter Nilsson
  • Patent number: 8710246
    Abstract: A compound is provided of the formula wherein each u is independently selected from 0 and 1; each R2 and R4 is independently selected from carboxy, carboxyalkyl, alkoxycarbonylalkyl, aminoalkyl, (amino)(carboxy)alkyl and (amino)(carboxy)alkoxy; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 19, 2009
    Date of Patent: April 29, 2014
    Assignee: Biochromix Newco AB
    Inventors: Peter Åsberg, Leif Johansson, Anna Herland, Andreas Åslund, Peter Konradsson
  • Publication number: 20130078701
    Abstract: The present disclosure relates to a device comprising a conductive substrate surface (19), at least one layer of a conductive polymer (14) deposited on the surface (19), a first electrolyte (13) arranged in contact with the conductive polymer layer, and a counter electrode (11), arranged in contact with the first electrolyte (13), such that a potential difference can be applied between the conductive substrate (15) and the counter electrode (11). The conductive polymer (14), in a first state, before applying the potential difference, exhibits a first adhesive capacity, wherein the conductive polymer layer (14) is substantially attached to the conductive substrate surface (19). In a second state, subsequent to application of the potential difference, the conductive polymer (14), exhibits a second adhesive capacity, such that at least a portion of the conductive polymer layer (14) is substantially released from the conductive substrate surface (19).
    Type: Application
    Filed: April 6, 2010
    Publication date: March 28, 2013
    Applicant: OBOE IPR AB
    Inventors: Kristin Persson, Roger Karlsson, Magnus Berggren, Peter Konradsson, Edwin Jager, Agneta Richter-Dahlfors, Karl Svennersten
  • Publication number: 20120315646
    Abstract: The present invention relates to oligothiophene derivatives binding specifically to neural stem cells and neural cancer stem cells. More specifically, the invention relates to methods for detecting neural stem cells or neural cancer stem cells using said oligothiophene derivatives in a biological sample, as well as uses and kits relating thereto.
    Type: Application
    Filed: February 15, 2011
    Publication date: December 13, 2012
    Applicant: CELLUMINOVA AB
    Inventors: Ola Hermansson, Peter Konradsson, Andreas Aslund, Shirin Ilkhanizadeh, Rozalyn Simon, Peter Nilsson
  • Publication number: 20120157516
    Abstract: The present invention relates to novel substituted thiophene derivatives useful in therapy of diseases related to misfolded and aggregated proteins.
    Type: Application
    Filed: October 19, 2009
    Publication date: June 21, 2012
    Inventors: Peter Åsberg, Leif Johansson, Anna Herland, Andreas Åslund, Peter Konradsson